Report
Dave Nicoski ...
  • Ross LaDuke
EUR 239.98 For Business Accounts Only

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

ETF outlook
Underlyings
Eden Research

Eden Research is engaged in the agrochemical product, 3AEY, a fungicide which targets botrytis on grapes, in both Spain and Italy.

ISHARES MSCI CHN

iShares MSCI Switzerland Cappe

iShares NASDAQ Biotechnology ETF

iShares U.S. Medical Devices E

KraneShares CSI China Internet Fund

VanEck Vectors Biotech ETF

VanEck Vectors Video Gaming & eSports ETF

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch